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Dermoscopy and reflectance
confocal microscopy featuresTo the Editor: Only case reports have analyzed the
dermoscopic and reflectance confocal microscopy
(RCM) features of the lesions of nipple and areola
complex (NAC).1-3 We retrospectively evaluated the
clinical, dermoscopic, and RCM features of 131
consecutive NAC lesions diagnosed at 13 University
Centers (Tables I and II). The final diagnosis was
based on histopathology or on clinical follow-up for
$1 year to confirm benignity. Three experts in
noninvasive skin imaging (EC, MA, and SG)
independently evaluated dermoscopic and RCM
criteria blinded from the diagnosis. Criteria were
considered present when $2 experts agreed
(Table II). A 7-point checklist4 and Pellacani criteria5
have been developed for melanocytic lesions but
were applied to all lesions because in the NAC it is
not always easy to clinically establish if lesions are
melanocytic or not. Considering Paget disease (PD)
and eczema, we found a statistically significant
difference for both for the presence of spongiosis
(Fisher exact test, P ¼ .017) and dark Paget cells
(P ¼ .038) under RCM but no difference for thepresence of dotted (P ¼ .587) and linear vessels
(P ¼ 1.000) and milky-red areas (P ¼ .052) under
dermoscopy.
Diagnostic accuracy of the 3 types of examination
was calculated on the agreement of $2 of 3
investigators for 79 lesions with clinical,
dermoscopic, and RCM images. Sensitivity and 95%
confidence intervals (95% CIs) for malignancy of the
clinical, dermoscopic, and RCM examination were
83% (73-90%), 67% (55-77%), and 83% (73-90%) and
specificity (95% CIs) were 90% (80-95%), 97%
(90-99%), and 94% (86-98%), respectively.
Specificity of dermoscopy for malignancy was high
despite the high number of false positive nevi on the
7-point checklist because experts likely gave their
dermoscopic diagnoses having clinical images
available and with a holistic assessment of
dermoscopic images. Sensitivity (95% CIs) for PD
of the clinical, dermoscopic, and RCM examination
were 100% (80-100%), 85% (62-96%), and 86%
(62-96%) and specificity (95% CIs) were 54%
(31-75%), 100% (80-100%), and 100% (80-100%),
respectively. Clinical examination had 100%
sensitivity because all unilateral plaques/patches
and erosions were possible PD. Conversely, RCM
and dermoscopy had 100% specificity for PD,
better than clinical examination. RCM superiority in
specificity was predictable because of the ability of
this technique to identify Paget cells and
spongiosis. Experts diagnosed PD in 86% of
cases at RCM, but it should be considered that
classic RCM presentation of Paget cells as
‘‘round and dark intraepidermal cavities’’ was
found in only half of PD cases (Table II). Although
there are no validated dermoscopic criteria for
eczema and PD of NAC, it is possible that a more
irregular vascular pattern in PD allowed the
differential diagnosis with eczema. Interinvestigator
agreement in the diagnosis evaluated by Fleiss kappa
increased from clinical ( poor or moderate) to
dermoscopic (moderate) and RCM (excellent)
examination. Although our study does not have the
ability to draw conclusions about primary
melanoma, noninvasive imaging techniques added
relevant information and seem to improve the
differential diagnosis of PD and eczema.
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Table I. Clinical features of the 131 lesions
MM PD Nevus Melanosis SK Eczema Miscellaneous* Total
No. of lesions 3 15 66 7 16 10 14 131
Lesion with histologic examination 3 15 21 2 3 8 13 65
Sex, n (%)
Male 0 1 (7) 7 (11) 0 5 (31) 2 (20) 0 15 (11)
Female 3 (100) 14 (93) 59 (89) 7 (100) 11 (69) 8 (80) 14 (100) 116 (89)
Patient age, y (SD)y
Mean age, y (SD) 70 (6) 64 (14) 33 (13) 34 (14) 54 (15) 47 (26) 57 (21) 43 (20)
Age range, y 65-77 39-91 8-71 18-54 30-81 16-73 24-91 8-91
Anatomic site, n (%)
Nipple 0 8 (54) 17 (26) 5 (72) 4 (25) 7 (70) 9 (64) 50 (38)
Areola 3 (100) 2 (13) 44 (67) 1 (14) 12 (75) 3 (30) 2 (14) 67 (51)
Both areola and nipple 0 5 (33) 5 (7) 1 (14) 0 0 3 (22) 14 (11)
Shape, n (%)
Macule/patch 1 (33) 3 (20) 55 (83) 6 (86) 4 (25) 1 (10) 6 (43) 76 (58)
Papule/nodule/plaque 2 (67) 12 (80) 11 (17) 1 (14) 12 (75) 9 (90) 8 (57) 55 (42)
Presence of pigmentation, n (%)
Yes 3 (100) 4 (27) 66 (100) 7 (100) 16 (100) 0 5 (36) 101 (77)
No 0 11 (73) 0 0 0 10 (100) 9 (64) 30 (23)
Lesion size, mm (SD)
Maximum diameter 6 (2) 21 (17) 7 (4) 4 (3) 6 (3) 24 (35) 8 (6) 9 (12)
Size range 5-9 2-50 1-20 1-8 3-10 3-100 2-20 1-100
Time to diagnosis, y (SD)
Mean time 0.2 (0.2) 1.1 (0.9) 10.6 (12) 2.4 (1.8) 3.4 (3.4) 0.5 (0.5) 0.9 (0.3) 7.4 (10.4)
Dermoscopy 3 13 66 7 15 7 14 125
RCM 2 11 37 6 11 9 9 85
Dermoscopy and RCM 2 9 37 6 10 6 9 79
MM, Melanoma; PD, Paget disease; RCM, reflectance confocal microscopy; SD, standard deviation; SK, seborrheic keratosis.
*One adenoma, 1 angioma, 1 pigmented Bowen disease, 2 erosive adenomatosis of the nipple, 1 epidermal cyst, 2 melanoacanthomas,
1 hematoma, 1 mycosis fungoides, 1 bullous pemphigoid, 1 case of skin xerosis, 1 case of Fordyce granules with histologic examination, and
1 radiodermatitis.
yPatients with malignant tumors were older than patients with benign lesions (a mean of 64 years [SD 12.9 years] and range of 39-91 years
for malignant tumors and a mean of 38.6 years [SD 17.8 years] and range of 8-91 years for benign lesions; t test, P\ .0001).
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No. of lesions with dermoscopic
images available
1 2 66 7 15 3 13 7




1 (100) 0 17 (25.8) 1 (14.3) 0 1 (33) 0 0
Blue-white veil (2 pts) 1 (100) 1 (50) 18 (27.3) 0 2 (13.3) 1 (33) 0 0
Atypical vascular pattern
(2 pts)
1 (100) 0 4 (6.1) 0 1 (6.7) 1 (33) 3 (23.1) 0
Irregular streaks (1 pt) 0 0 4 (6.1) 0 0 1 (33) 0 0
Regression structures
(1 pt)
1 (33) 0 9 (13.6) 1 (14.3) 0 1 (33) 6 (46.15) 0
Blotches irregularly
distributed (1 pt)
0 0 5 (7.6) 0 0 0 1 (7.7) 0
Irregular dots/globules
(1 pt)
0 0 7 (10.6) 0 1 (6.7) 1 (33) 0 0
Lesions with total score
$3
1 (100) 0 16 (24.2) 1 (14.3) 1 (6.7) 1 (33) 2 (15.4) 0
Other dermoscopic criteria,
n (%)
Gray-blue pigmentation 0 1 (50) 17 (25.8) 0 1 (6.7) 1 (33) 1 (7.7) 0
Milia-like cysts 0 0 4 (6.1) 0 2 (13.3) 0 0 0
Comedo-like openings 0 0 1 (1.5) 0 5 (33.3) 0 0 0
Dotted vessels 0 0 0 0 1 (6.7) 0 2 (15.38) 2 (28.57)
Linear vessels 0 1 (50) 0 0 0 0 5 (38.46) 2 (28.57)
Milky-red areas 0 0 0 0 0 0 6 (46.15) 0
No. of lesions with RCM images available 1 1 37 6 11 2 11 9
RCM criteria of the Pellacani et al
score, n (%)
Atypical cells at the DEJ
(2 pts)
1 (100) 0 5 (13.5) 0 1 (9) 0 0 0
Nonedged papillae (2 pts) 1 (100) 0 3 (8.1) 0 0 0 1 (9) 0
Roundish pagetoid cells
(1 pt)
1 (100) 0 1 (2.7) 0 0 1 (50) 1 (9) 0
Widespread dendritic
pagetoid cells (1 pt)
0 0 10 (27) 0 0 0 1 (9)
Cerebriform nests (1 pt) 0 0 0 0 0 0 0 0
Nucleated cells within
upper dermis (1 pt)
0 1 (100) 0 0 0 0 0 0
Lesions with total score
$3
1 (100) 0 5 (13.5) 0 0 0 0 0
Other RCM criteria, n (%)
Dark Paget cells 0 0 0 0 0 0 5 (45.5) 0
Spongiosis 0 0 0 0 1 (9) 0 1 (9.1) 6 (66.7)
DEJ, Dermoepidermal junction; MM, Melanoma; PD, Paget disease; pt, point; RCM, reflectance confocal microscopy; SD, standard deviation;
SK, seborrheic keratosis.
Dermoscopy was performed at 320 magnification and RCM images were acquired with VivaScope 3000 (51 cases) or 1500 probe (34 cases)
(Caliber Imaging and Diagnostics, Rochester, NY). Only images considered relevant for the diagnosis by an RCM expert were captured by
RCM. Images of different depths (epidermis, DEJ, and dermis) were always present.
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https://doi.org/10.1016/j.jaad.2018.11.017A review of smartphone
applications for promoting sun
protection practicesTo the Editor: Primary prevention of skin cancer is
best achieved by protecting the skin from exposure
to ultraviolet (UV) radiation; exposure to UV
radiation increases the risk for both melanoma and
nonmelanoma skin cancers.1 The US Preventive
Task Force recommends that children and adults
be counseled on using sun protection practices to
minimize UV exposure and suggests that mobile
smartphone applications might be useful to facilitate
these behaviors.2 The effectiveness of smartphone
applications to promote a variety of health behaviors
targeting exercise performance, weight loss, diet,
smoking cessation, alcohol consumption, and sun
protection has been examined in the published
literature.3 Skin cancer prevention is particularly
amenable to intervention from smartphone
applications by helping individuals monitor UV
exposure and provide tailored recommendations
and reminders for protecting their skin. Dozens of
applications of varying quality are currently
available, making it difficult for interested users to
find applications with useful, intuitive, and effective
features.
The purpose of this study was to provide a
comprehensive list of currently available sun
protection smartphone applications and their
features. In August 2018, we searched the Apple
(Cupertino, CA) and Android (Google, Menlo Park,
CA) App stores for applications that promote sun
protection practices. Search terms included ‘‘skincancer,’’ ‘‘sun,’’ ‘‘UV protection,’’ and ‘‘melanoma.’’
Results were screened according to predefined
inclusion and exclusion criteria. Smartphone
apps were included if they provided specific, person-
alized advice regarding sun protection using local UV
indices and the user’s personal skin characteristics.We
excluded apps that only provided weather, UV infor-
mation, or general recommendations and those that
were not in English, were country specific, or not for
patient use. We also excluded apps that were
incompatible with the latest smartphone operating
systems and that required purchase of a wearable UV
dosimeter. Last, we compared apps on the basis of
features that have been shown to improve the
effectiveness of apps targeting behavior change,
such as having a user-friendly design, providing
real-time feedback, and offering tailored advice
supplemented by additional information.4
Our search revealed 1060 results across both app
stores (including duplicates), from which we identi-
fied 9 eligible apps (Table I). Most apps were user
friendly, intuitive, and provided personalized sun
protection recommendations tailored to user skin
type and color. Recommendations included avoiding
being outdoors during periods of high UV light, a
minimum sunscreen sun protection factor and time
until reapplication, and types of physical protection
(ie, clothing, hats, and sunglasses). However, we
found limited published evidence regarding the
effectiveness of these apps for facilitating sun pro-
tection behaviors. In fact, only SunZapp developers
(Klein Buendel Inc, Golden, CO) provided citations
to 3 published studies showing limited improvement
in sun protection.5 We found most apps included in
this review to be easy to use while providing instant
feedback and tailored recommendations to users,
but only SunSense (Raymio, Copenhagen, Denmark)
satisfied all criteria by offering additional information
about sun protection. Although we have identified
several apps with the potential to promote sun
safety, further investigation is required to establish
whether their use results in sustained behavior
change and reductions in UV exposure. Future
research should also consider comparing apps that
utilize wearable technology for real-time UV tracking
and those that rely on regional UV indices.
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